Riccardo M Inciardi1,2, Robert P Giugliano3, Brian Claggett1, Deepak K Gupta4, Alvin Chandra1, Christian T Ruff3, Elliott M Antman3, Michele F Mercuri5, Michael A Grosso5, Eugene Braunwald3, Scott D Solomon1. 1. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 2. Division of Cardiology, Department of Medicine, University Hospital of Verona, Verona, Italy. 3. TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 4. Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Cardiovascular, Metabolic and Renal Disease Therapeutic Area, Global Clinical Development, Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA.
Abstract
AIMS: The present study aimed to assess the association between left atrial (LA) structure and function and the risk for cardiovascular (CV) death or heart failure (HF) hospitalization in a population with atrial fibrillation (AF). METHODS AND RESULTS: In a prospective echocardiographic substudy of the Effective Anticoagulation with Factor Xa Next Generation in AF-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) study, 971 patients underwenttransthoracic echocardiography. The associations between LA structure (LA volume index [LAVi]) and function (LA emptying fraction [LAEF] and LA expansion index [LAEi]) and risk for the composite endpoint of CV death or HF hospitalization, and its components, were assessed. Over a median follow-up of 2.5 years, 142 patients (14.6%) experienced CV death or HF hospitalization. Higher LAVi and lower LAEF and LAEi were each associated with a higher unadjusted risk for the composite outcome and its components. After adjustment for clinical and echocardiographic confounders, only measures of impaired LA function were predictive of the composite outcome (hazard ratio [HR] per 1 standard deviation [SD] decrease in LAEF: 1.35; 95% confidence interval [CI] 1.09-1.67 [P = 0.005]; HR per 1 SD decrease in LAEi: 1.34; 95% CI 1.06-1.69 [P = 0.012]). These findings were similar regardless of left ventricular ejection fraction, history of HF or whether patients were in AF or sinus rhythm at the time of the echocardiographic examination. CONCLUSIONS: In patients with AF, LA dysfunction was significantly associated with an increased risk for CV death or HF hospitalization and was more predictive of these outcomes than LA size. These parameters may help to identify AF patients at greatest risk for the development of HF. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT00781391.
RCT Entities:
AIMS: The present study aimed to assess the association between left atrial (LA) structure and function and the risk for cardiovascular (CV) death or heart failure (HF) hospitalization in a population with atrial fibrillation (AF). METHODS AND RESULTS: In a prospective echocardiographic substudy of the Effective Anticoagulation with Factor Xa Next Generation in AF-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) study, 971 patients underwent transthoracic echocardiography. The associations between LA structure (LA volume index [LAVi]) and function (LA emptying fraction [LAEF] and LA expansion index [LAEi]) and risk for the composite endpoint of CV death or HF hospitalization, and its components, were assessed. Over a median follow-up of 2.5 years, 142 patients (14.6%) experienced CV death or HF hospitalization. Higher LAVi and lower LAEF and LAEi were each associated with a higher unadjusted risk for the composite outcome and its components. After adjustment for clinical and echocardiographic confounders, only measures of impaired LA function were predictive of the composite outcome (hazard ratio [HR] per 1 standard deviation [SD] decrease in LAEF: 1.35; 95% confidence interval [CI] 1.09-1.67 [P = 0.005]; HR per 1 SD decrease in LAEi: 1.34; 95% CI 1.06-1.69 [P = 0.012]). These findings were similar regardless of left ventricular ejection fraction, history of HF or whether patients were in AF or sinus rhythm at the time of the echocardiographic examination. CONCLUSIONS: In patients with AF, LA dysfunction was significantly associated with an increased risk for CV death or HF hospitalization and was more predictive of these outcomes than LA size. These parameters may help to identify AFpatients at greatest risk for the development of HF. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT00781391.
Authors: Scott D Solomon; Elyse Foster; Mikhail Bourgoun; Amil Shah; Esperanza Viloria; Mary W Brown; W Jackson Hall; Marc A Pfeffer; Arthur J Moss Journal: Circulation Date: 2010-08-23 Impact factor: 29.690
Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas Journal: Eur Heart J Date: 2016-08-27 Impact factor: 29.983
Authors: Alanna M Chamberlain; Bernard J Gersh; Alvaro Alonso; Lin Y Chen; Cecilia Berardi; Sheila M Manemann; Jill M Killian; Susan A Weston; Véronique L Roger Journal: Am J Med Date: 2014-11-08 Impact factor: 4.965
Authors: Giulia Magnani; Robert P Giugliano; Christian T Ruff; Sabina A Murphy; Francesco Nordio; Marco Metra; Tiziano Moccetti; Veselin Mitrovic; Minggao Shi; Michele Mercuri; Elliott M Antman; Eugene Braunwald Journal: Eur J Heart Fail Date: 2016-06-28 Impact factor: 15.534
Authors: Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray Journal: Circulation Date: 2013-12-17 Impact factor: 29.690
Authors: Alessandra Meris; Maria Amigoni; Hajime Uno; Jens Jakob Thune; Anil Verma; Lars Køber; Mikhail Bourgoun; John J McMurray; Eric J Velazquez; Aldo P Maggioni; Jalal Ghali; J Malcolm O Arnold; Steven Zelenkofske; Marc A Pfeffer; Scott D Solomon Journal: Eur Heart J Date: 2008-11-11 Impact factor: 29.983
Authors: Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho Journal: Circulation Date: 2016-01-08 Impact factor: 29.690
Authors: Wendy Wang; Michael J Zhang; Riccardo M Inciardi; Faye L Norby; Michelle C Johansen; Romil Parikh; Jeremy R Van't Hof; Alvaro Alonso; Elsayed Z Soliman; Thomas H Mosley; Rebecca F Gottesman; Amil M Shah; Scott D Solomon; Lin Yee Chen Journal: JAMA Date: 2022-03-22 Impact factor: 157.335
Authors: Javier Bermejo; Ana González-Mansilla; Teresa Mombiela; Ana I Fernández; Pablo Martínez-Legazpi; Raquel Yotti; Rocío García-Orta; Pedro L Sánchez-Fernández; Mario Castaño; Javier Segovia-Cubero; Pilar Escribano-Subias; J Alberto San Román; Xavier Borrás; Angel Alonso-Gómez; Javier Botas; María G Crespo-Leiro; Sonia Velasco; Antoni Bayés-Genís; Amador López; Roberto Muñoz-Aguilera; Manuel Jiménez-Navarro; José R González-Juanatey; Arturo Evangelista; Jaime Elízaga; Javier Martín-Moreiras; José M González-Santos; Eduardo Moreno-Escobar; Francisco Fernández-Avilés Journal: J Am Heart Assoc Date: 2021-01-05 Impact factor: 5.501
Authors: Wendy Wang; Faye L Norby; Michael J Zhang; Jorge L Reyes; Amil M Shah; Elsayed Z Soliman; Pamela L Lutsey; Alvaro Alonso; Scott D Solomon; Riccardo M Inciardi; Lin Y Chen Journal: J Am Heart Assoc Date: 2021-10-29 Impact factor: 5.501
Authors: Riccardo M Inciardi; Brian Claggett; Deepak K Gupta; Susan Cheng; Jiankang Liu; Justin B Echouffo Tcheugui; Chiadi Ndumele; Kunihiro Matsushita; Elizabeth Selvin; Scott D Solomon; Amil M Shah; Hicham Skali Journal: J Am Heart Assoc Date: 2022-03-05 Impact factor: 6.106